Ignite Creation Date:
2024-05-06 @ 1:32 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04051944
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2019-08-08
Brief Title:
A Study to Assess Long-term Safety Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
CIDP04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Biopharma SRL
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None